Vulvovaginal candidiasis is a common problem; at one time or another most women experience at least one episode of this bothersome condition. For the past several years, the pharmaceutical industry has convinced women that this condition is easily treated and that they should recognize the symptoms of vulvovaginal candidiasis. Our concern should be to ensure that the treatment is specific and that an associated condition is not present that can place the patient in jeopardy of compromising her reproductive capabilities.
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I believe that the infectious diseases societies must, once again, awaken our colleagues and raise the level of awareness regarding infectious diseases. We need to bring attention to all the conditions in the vaginal ecosystem that impact on women's health. This should be done not by rephrasing the same old song, but bringing our specialty into the twenty-first century by making our scientific data applicable to everyday clinical situations. Now is an opportune time for both societies to step forward, to be proactive and to make recommendations, and to work together to improve the health of women.
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